Geneoscopy

Saint Louis, United States

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

$105.0M raised

Jan 2025

Series C

Top Investors

LabCorpCultivation CapitalBio-Rad LaboratoriesDorm Room FundPetrichor Healthcare Capital Management

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Geneoscopy raised?

Geneoscopy has raised $105.0M in total funding. The most recent round was Series C. The last funding was announced in January 2025.

Who are Geneoscopy's investors?

Geneoscopy's investors include LabCorp, Cultivation Capital, Bio-Rad Laboratories, Dorm Room Fund, Petrichor Healthcare Capital Management.

Where is Geneoscopy headquartered?

Geneoscopy is headquartered in Saint Louis, United States.

What does Geneoscopy do?

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

What stage is Geneoscopy at?

Geneoscopy is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 8, 2025.

MLA

"Geneoscopy — Funding & Investors." VCBacked, January 8, 2025, https://www.vcbacked.co/company/geneoscopy. Accessed June 4, 2026.

APA

VCBacked. (2025). Geneoscopy — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/geneoscopy

Wikipedia (cite web)

{{cite web |title=Geneoscopy — Funding & Investors |url=https://www.vcbacked.co/company/geneoscopy |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 8, 2025.